Intel, Core BTS, Salesforce, Verizon, ServiceNow, Cisco and Cyderes were among the tech companies making key executive hires ...

Mass Eye and Ear, Harvard Medical School, Boston, USA); Alan Robin (Johns Hopkins University ... USA); Tueng Shen (University of Washington, Seattle, USA); Rajesh Shetty (Mayo Clinic, Minnesota, USA); ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500 ...

As a medical oncologist who has practiced in three different countries, Dr. Maria Alice Franzoi is well acquainted with ...

With support from the Gilead Research Scholars Program (RSP ... an assistant professor at George Washington University whose research through the RSP focuses on ovarian cancer.

In its first quarter 2025 investor letter, ClearBridge Value Strategy emphasized stocks such as Gilead Sciences, Inc. (NASDAQ:GILD). Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company.

Headquartered in Foster City, CA, Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus (HIV). The company’s broad portfolio includes drugs for liver ...

In the latest trading session, Gilead Sciences (GILD) closed at $105.25, marking a +2% move from the previous day. The stock lagged the S&P 500's daily gain of 9.52%. Elsewhere, the Dow saw an ...